AU8445491A - Entamoeba histolytica immunodominant surface antigens - Google Patents

Entamoeba histolytica immunodominant surface antigens

Info

Publication number
AU8445491A
AU8445491A AU84454/91A AU8445491A AU8445491A AU 8445491 A AU8445491 A AU 8445491A AU 84454/91 A AU84454/91 A AU 84454/91A AU 8445491 A AU8445491 A AU 8445491A AU 8445491 A AU8445491 A AU 8445491A
Authority
AU
Australia
Prior art keywords
surface antigens
entamoeba histolytica
immunodominant surface
immunodominant
histolytica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84454/91A
Inventor
Nina Martha Agabian
Ursula Edman
Isaura Meza Gomez-Palacio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU8445491A publication Critical patent/AU8445491A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU84454/91A 1990-08-24 1991-08-21 Entamoeba histolytica immunodominant surface antigens Abandoned AU8445491A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57291690A 1990-08-24 1990-08-24
US572916 1990-08-24

Publications (1)

Publication Number Publication Date
AU8445491A true AU8445491A (en) 1992-03-17

Family

ID=24289889

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84454/91A Abandoned AU8445491A (en) 1990-08-24 1991-08-21 Entamoeba histolytica immunodominant surface antigens

Country Status (6)

Country Link
EP (1) EP0550465A1 (en)
JP (1) JPH06500548A (en)
AU (1) AU8445491A (en)
BR (1) BR9106968A (en)
MX (1) MX9100808A (en)
WO (1) WO1992003457A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012271A2 (en) * 2000-08-04 2002-02-14 Jeffrey Howard Treatment of microbial infections with bacterial proteins and peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426462D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
US5004608A (en) * 1988-01-13 1991-04-02 The University Of Virginia Alumni Patents Foundation Amebiasis vaccine

Also Published As

Publication number Publication date
EP0550465A4 (en) 1994-04-06
JPH06500548A (en) 1994-01-20
MX9100808A (en) 1992-11-01
WO1992003457A1 (en) 1992-03-05
EP0550465A1 (en) 1993-07-14
BR9106968A (en) 1993-09-21

Similar Documents

Publication Publication Date Title
GB9107724D0 (en) Surface covering
AU9052091A (en) Vaccines based on hepatitis b surface antigen
ZA918562B (en) Novel thiazolidinediones
AU627403B2 (en) Electromagnetic clutch
GB9011605D0 (en) Friction bonding
EP0474036A3 (en) Optical material
EP0469897A3 (en) Engineered antibodies
AU7965191A (en) Mop
AU8445491A (en) Entamoeba histolytica immunodominant surface antigens
GB9200930D0 (en) Surface covering
EP0463612A3 (en) Optical material
AU643308B2 (en) 2-(9-fluorenonyl)-carbapenem
AU6471690A (en) A novel tumor-associated antigen
AU7862291A (en) Modified antibodies
GB9014652D0 (en) Antigen
AU637468B2 (en) Plasmodium sporozoite antigen
GB9011808D0 (en) Spring-loading cardboard structures
GB9004763D0 (en) Transducer
RU1799839C (en) Grab
AU630305B2 (en) Quilt
GB9013419D0 (en) Antibodies
GB9211317D0 (en) Novel antigens
AU625407B1 (en) Electromagnetic position transducer
GB9117602D0 (en) Novel antigens
GB9122301D0 (en) Novel antigens